Alyeska Investment Group
PBH icon

Alyeska Investment Group’s Prestige Consumer Healthcare PBH Stock Holding History

Alyeska Investment Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-110,000
Closed -$3.73M – 435
2014
Q2 		$3.73M Buy
+110,000
New +$3.52M 0.08% 259

Other funds holding PBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Alyeska Investment Group's PBH Position: Q3 2014 in Review

Alyeska Investment Group sold out of Prestige Consumer Healthcare (PBH) in Q3 2014, closing a stake of 110,000 shares — an estimated $3.73M sold.

Alyeska Investment Group first reported a position in PBH in Q2 2014 and held it in 1 quarter. The position peaked at $3.73M in Q2 2014. 174 funds tracked by Wall St. Rank hold PBH as of Q3 2014.

  • Alyeska Investment Group reported no remaining Prestige Consumer Healthcare position as of Q3 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 110,000 Prestige Consumer Healthcare shares in Q3 2014, an estimated $3.73M.
  • Alyeska Investment Group first reported a position in Prestige Consumer Healthcare in Q2 2014 and held it in 1 quarter.
  • Alyeska Investment Group's Prestige Consumer Healthcare position peaked at $3.73M in Q2 2014.
  • 174 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2014.

Based on Alyeska Investment Group's 13F filing for Q3 2014, filed 14 Nov 2014.